Protective effect of tolvaptan against cyclophosphamide‐induced nephrotoxicity in rat models

Cyclophosphamide (CP) is a chemotherapeutic agent which is extensively used in the treatment of multiple neoplastic and nonneoplastic diseases like breast cancer, lymphomas, systemic lupus erythematosus, and multiple sclerosis. Dose‐limiting side effects, mainly nephrotoxicity is a major problem hin...

Descripción completa

Detalles Bibliográficos
Autores principales: El‐Shabrawy, Mohamed, Mishriki, Amal, Attia, Hisham, Emad Aboulhoda, Basma, Emam, Mohamed, Wanas, Hanaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525803/
https://www.ncbi.nlm.nih.gov/pubmed/32996719
http://dx.doi.org/10.1002/prp2.659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525803/
https://www.ncbi.nlm.nih.gov/pubmed/32996719
http://dx.doi.org/10.1002/prp2.659

Ejemplares similares